CLGN
Collplant Biotechnologies Ltd
NASDAQ: CLGN · HEALTHCARE · BIOTECHNOLOGY
$0.37
-4.51% today
Updated 2026-04-29
Market cap
$6.00M
P/E ratio
—
P/S ratio
2.53x
EPS (TTM)
$-0.94
Dividend yield
—
52W range
$0 – $5
Volume
0.1M
Collplant Biotechnologies Ltd (CLGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |